Skip to content

Germany's pharmacy reforms tighten mail-order drug temperature rules

Higher prices and delivery delays loom as Germany enforces tougher rules on medication shipments. Who will bear the brunt of these sweeping pharmacy reforms?

The image shows a pharmacy shelf filled with lots of different types of medicines, including boxes...
The image shows a pharmacy shelf filled with lots of different types of medicines, including boxes and other objects arranged neatly on the racks.

Germany's pharmacy reforms tighten mail-order drug temperature rules

New pharmacy reforms in Germany will introduce stricter temperature controls for mail-order medications. The changes aim to improve safety but will raise costs and complicate deliveries. Patients, particularly vulnerable groups, may find it harder to access essential drugs as a result.

Under the updated rules, mail-order pharmacies must now document every step of the supply chain and monitor temperatures continuously. Special packaging and electronic loggers will be mandatory, adding layers of complexity to shipping. These measures could push the average shipping cost per package up by 4 to 5 euros.

A 40-euro medication order might see a 10 to 12 percent price hike due to the new demands. Annual expenses for mail-order pharmacies could climb to between 5 and 6.25 million euros, forcing some to partner with specialist logistics firms or develop their own delivery networks. The reforms may also delay the availability of certain specialised drugs, worsening supply issues in some areas. Elderly, chronically ill, or mobility-impaired patients—along with those in remote regions—face the greatest risks. Over two million Germans already travel longer distances to reach a pharmacy after recent closures. Higher shipping costs and potential shortages could further limit their access to vital treatments.

The reforms will increase costs for both pharmacies and patients while tightening oversight of medication deliveries. Vulnerable groups may struggle the most, with longer waits and higher expenses for essential drugs. The full impact on supply chains and patient access will become clearer once the rules take effect.

Read also:

Latest